Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Planning for the Rheumatologist Workforce: Factors Associated With Work Hours and Volumes.

Barber CEH, Nasr M, Barnabe C, Badley EM, Lacaille D, Pope J, Cividino A, Yacyshyn E, Baillie C, Mosher D, Thomson JG, Charnock C, Thorne JC, Zummer M, Brophy J, Ruban TN, Ahluwalia V, McDougall R, Marshall DA.

J Clin Rheumatol. 2018 May 25. doi: 10.1097/RHU.0000000000000803. [Epub ahead of print]

PMID:
29846270
2.

Development of a Canadian Core Clinical Dataset to Support High-quality Care for Canadian Patients with Rheumatoid Arthritis.

Barber CEH, Mosher DP, Ahluwalia V, Zummer M, Marshall DA, Choquette D, Lacaille D, Bombardier C, Lyddiatt A, Chandran V, Khodyakov D, Dao E, Barnabe C; RACCD Working Group.

J Rheumatol. 2017 Dec;44(12):1813-1822. doi: 10.3899/jrheum.170421. Epub 2017 Oct 1.

3.

Real-world validation of the minimal disease activity index in psoriatic arthritis: an analysis from a prospective, observational, biological treatment registry.

Rahman P, Zummer M, Bessette L, Baer P, Haraoui B, Chow A, Kelsall J, Kapur S, Rampakakis E, Psaradellis E, Lehman AJ, Nantel F, Osborne B, Tkaczyk C.

BMJ Open. 2017 Aug 30;7(8):e016619. doi: 10.1136/bmjopen-2017-016619.

4.

Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice.

Gladman DD, Poulin Y, Adams K, Bourcier M, Barac S, Barber K, Chandran V, Dutz J, Flanagan C, Gooderham MJ, Gulliver WP, Ho VC, Hong CH, Karsh J, Khraishi MM, Lynde CW, Papp KA, Rahman P, Rohekar S, Rosen CF, Russell AS, Vender RB, Yeung J, Ziouzina O, Zummer M.

J Rheumatol. 2017 Apr;44(4):519-534. doi: 10.3899/jrheum.161473.

PMID:
28604347
5.

Stand Up and Be Counted: Measuring and Mapping the Rheumatology Workforce in Canada.

Barber CE, Jewett L, Badley EM, Lacaille D, Cividino A, Ahluwalia V, Averns H, Baillie C, Ellsworth J, Pope J, Levy D, Charnock C, McGowan C, Thorne JC, Barnabe C, Zummer M, Lundon K, McDougall RS, Thomson JG, Yacyshyn EA, Mosher D, Brophy J, Ruban TN, Marshall DA.

J Rheumatol. 2017 Feb;44(2):248-257. doi: 10.3899/jrheum.160621. Epub 2016 Dec 1.

PMID:
27909087
6.

Review of Current Workforce for Rheumatology in the Countries of the Americas 2012-2015.

Reveille JD, Muñoz R, Soriano E, Albanese M, Espada G, Lozada CJ, Montúfar RA, Neubarth F, Vasquez GM, Zummer M, Sheen R, Caballero-Uribe CV, Pineda C.

J Clin Rheumatol. 2016 Dec;22(8):405-410.

PMID:
27870762
7.

Influence of Education on Disease Activity and Damage in Systemic Lupus Erythematosus: Data From the 1000 Canadian Faces of Lupus.

George A, Wong-Pak A, Peschken CA, Silverman E, Pineau C, Smith CD, Arbillaga H, Zummer M, Bernatsky S, Hudson M, Hitchon C, Fortin PR, Nevskaya T, Pope JE; 1000 Canadian Faces of Lupus Investigators.

Arthritis Care Res (Hoboken). 2017 Jan;69(1):124-132. doi: 10.1002/acr.22922. Epub 2016 Nov 21. Erratum in: Arthritis Care Res (Hoboken). 2017 Mar;69(3):458.

8.

Biologic Treatment Registry Across Canada (BioTRAC): a multicentre, prospective, observational study of patients treated with infliximab for ankylosing spondylitis.

Rahman P, Choquette D, Bensen WG, Khraishi M, Chow A, Zummer M, Shaikh S, Sheriff M, Dixit S, Sholter D, Psaradellis E, Sampalis JS, Letourneau V, Lehman AJ, Nantel F, Rampakakis E, Otawa S, Shawi M.

BMJ Open. 2016 Apr 5;6(4):e009661. doi: 10.1136/bmjopen-2015-009661.

9.

The frequency of and associations with hospitalization secondary to lupus flares from the 1000 Faces of Lupus Canadian cohort.

Lee J, Peschken CA, Muangchan C, Silverman E, Pineau C, Smith CD, Arbillaga H, Zummer M, Clarke A, Bernatsky S, Hudson M, Hitchon C, Fortin PR, Pope JE.

Lupus. 2013 Nov;22(13):1341-8. doi: 10.1177/0961203313505689. Epub 2013 Sep 18.

PMID:
24048215
10.

Cancer risk in systemic lupus: an updated international multi-centre cohort study.

Bernatsky S, Ramsey-Goldman R, Labrecque J, Joseph L, Boivin JF, Petri M, Zoma A, Manzi S, Urowitz MB, Gladman D, Fortin PR, Ginzler E, Yelin E, Bae SC, Wallace DJ, Edworthy S, Jacobsen S, Gordon C, Dooley MA, Peschken CA, Hanly JG, Alarcón GS, Nived O, Ruiz-Irastorza G, Isenberg D, Rahman A, Witte T, Aranow C, Kamen DL, Steinsson K, Askanase A, Barr S, Criswell LA, Sturfelt G, Patel NM, Senécal JL, Zummer M, Pope JE, Ensworth S, El-Gabalawy H, McCarthy T, Dreyer L, Sibley J, St Pierre Y, Clarke AE.

J Autoimmun. 2013 May;42:130-5. doi: 10.1016/j.jaut.2012.12.009. Epub 2013 Feb 12.

11.

Association of smoking with cutaneous manifestations in systemic lupus erythematosus.

Bourré-Tessier J, Peschken CA, Bernatsky S, Joseph L, Clarke AE, Fortin PR, Hitchon C, Mittoo S, Smith CD, Zummer M, Pope J, Tucker L, Hudson M, Arbillaga H, Esdaile J, Silverman E, Chédeville G, Huber AM, Belisle P; Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus 1000 Canadian Faces of Lupus Investigators, Pineau CA.

Arthritis Care Res (Hoboken). 2013 Aug;65(8):1275-80. doi: 10.1002/acr.21966.

12.

Psoriatic arthritis in Canadian clinical practice: the PsA assessment in rheumatology.

Gladman DD, Chandran V, Thavaneswaran A, Zummer M.

J Rheumatol. 2012 Sep;39(9):1850-3. doi: 10.3899/jrheum.120282. Epub 2012 Aug 1.

PMID:
22859361
13.

Canadian Rheumatology Association recommendations for the pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs: part II safety.

Bombardier C, Hazlewood GS, Akhavan P, Schieir O, Dooley A, Haraoui B, Khraishi M, Leclercq SA, Légaré J, Mosher DP, Pencharz J, Pope JE, Thomson J, Thorne C, Zummer M, Gardam MA, Askling J, Bykerk V; Canadian Rheumatology Association.

J Rheumatol. 2012 Aug;39(8):1583-602. doi: 10.3899/jrheum.120165. Epub 2012 Jun 15.

14.

Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort.

Borowoy AM, Pope JE, Silverman E, Fortin PR, Pineau C, Smith CD, Arbillaga H, Gladman D, Urowitz M, Zummer M, Hudson M, Tucker L, Peschken C.

Semin Arthritis Rheum. 2012 Oct;42(2):179-85. doi: 10.1016/j.semarthrit.2012.03.011. Epub 2012 May 16.

PMID:
22595642
15.

Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs.

Bykerk VP, Akhavan P, Hazlewood GS, Schieir O, Dooley A, Haraoui B, Khraishi M, Leclercq SA, Légaré J, Mosher DP, Pencharz J, Pope JE, Thomson J, Thorne C, Zummer M, Bombardier C; Canadian Rheumatology Association.

J Rheumatol. 2012 Aug;39(8):1559-82. doi: 10.3899/jrheum.110207. Epub 2011 Sep 15.

16.

Canadian recommendations for clinical trials of pharmacologic interventions in rheumatoid arthritis: inclusion criteria and study design.

Karsh J, Keystone EC, Haraoui B, Thorne JC, Pope JE, Bykerk VP, Maksymowych WP, Zummer M, Bensen WG, Kraishi MM; Canadian Rheumatology Research Consortium.

J Rheumatol. 2011 Oct;38(10):2095-104. doi: 10.3899/jrheum.110188. Epub 2011 Jul 15. Review.

17.

The Spondyloarthritis Research Consortium of Canada registry for spondyloarthritis.

Gladman DD, Rahman P, Cook RJ, Shen H, Zummer M, Thomson G, Nair B, Rohekar S, Ayearst R, Inman RD, Maksymowych WP.

J Rheumatol. 2011 Jul;38(7):1343-8. doi: 10.3899/jrheum.101102. Epub 2011 Apr 15.

PMID:
21498484
18.

Medication use in systemic lupus erythematosus.

Bernatsky S, Peschken C, Fortin PR, Pineau CA, Urowitz MB, Gladman DD, Pope JE, Hudson M, Zummer M, Smith CD, Arbillaga HO, Clarke AE; Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS).

J Rheumatol. 2011 Feb;38(2):271-4. doi: 10.3899/jrheum.100414. Epub 2010 Nov 15. Erratum in: J Rheumatol. 2012 Mar;39(3):667. Pineau, Christi A [corrected to Pineau, Christian A].

PMID:
21078722
19.

A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles.

Budarf ML, Goyette P, Boucher G, Lian J, Graham RR, Claudio JO, Hudson T, Gladman D, Clarke AE, Pope JE, Peschken C, Smith CD, Hanly J, Rich E, Boire G, Barr SG, Zummer M; GenES Investigators, Fortin PR, Wither J, Rioux JD.

Genes Immun. 2011 Jan;12(1):51-8. doi: 10.1038/gene.2010.47. Epub 2010 Oct 21.

PMID:
20962850
20.

Optimal care for rheumatoid arthritis: a focus group study.

Bernatsky S, Feldman D, De Civita M, Haggerty J, Tousignant P, Legaré J, Zummer M, Meagher T, Mill C, Roper M, Lee J.

Clin Rheumatol. 2010 Jun;29(6):645-57. doi: 10.1007/s10067-010-1383-9. Epub 2010 Feb 3.

PMID:
20127397
21.

Clinical and serologic factors associated with lupus pleuritis.

Mittoo S, Gelber AC, Hitchon CA, Silverman ED, Pope JE, Fortin PR, Pineau C, Smith CD, Arbillaga H, Gladman DD, Urowitz MB, Zummer M, Clarke AE, Bernatsky S, Hudson M, Tucker LB, Petty RE; Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS), Peschken CA.

J Rheumatol. 2010 Apr;37(4):747-53. doi: 10.3899/jrheum.090249. Epub 2010 Jan 28.

PMID:
20110526
22.

Biopsychosocial determinants of physical and mental fatigue in patients with spondyloarthropathy.

Da Costa D, Zummer M, Fitzcharles MA.

Rheumatol Int. 2011 Apr;31(4):473-80. doi: 10.1007/s00296-009-1250-7. Epub 2009 Dec 20.

PMID:
20091037
23.

Determinants of sleep problems in patients with spondyloarthropathy.

Da Costa D, Zummer M, Fitzcharles MA.

Musculoskeletal Care. 2009 Sep;7(3):143-61. doi: 10.1002/msc.155.

PMID:
19422064
24.

The 1000 Canadian faces of lupus: determinants of disease outcome in a large multiethnic cohort.

Peschken CA, Katz SJ, Silverman E, Pope JE, Fortin PR, Pineau C, Smith CD, Arbillaga HO, Gladman DD, Urowitz M, Zummer M, Clarke A, Bernatsky S, Hudson M; Canadian Network for Improved Outcomes in Systemic Lupus Erythematosus (CaNIOS).

J Rheumatol. 2009 Jun;36(6):1200-8. doi: 10.3899/jrheum.080912. Epub 2009 Apr 15.

PMID:
19369456
25.

Clarifying the barriers to optimal healthcare for persons with inflammatory arthritis.

Bernatsky S, Feldman DE, Dawes M, Legare J, Mill C, Zummer M, Lee J.

J Rheumatol. 2009 Apr;36(4):852-3; author reply 853-4. doi: 10.3899/jrheum.080833. No abstract available.

PMID:
19342725
26.

Evaluation of the clinimetric properties of the Early Inflammatory Arthritis--self-administered comorbidity questionnaire.

Baron M, Schieir O, Hudson M, Steele R, Janelle-Montcalm A, Bernstein J, Starr M, Gagné M, Stein M, Kang H, Kapusta M, Couture F, Fitzcharles MA, Garfield B, Ménard HA, Berkson L, Pineau C, Gutkowski A, Zummer M, Mathieu JP, Mercille S, Ligier S, Krasny J, Bertrand C, Yuen SY, Schulz J.

Rheumatology (Oxford). 2009 Apr;48(4):390-4. doi: 10.1093/rheumatology/ken504. Epub 2009 Feb 4.

PMID:
19193697
27.

Symptoms of depression predict the trajectory of pain among patients with early inflammatory arthritis: a path analysis approach to assessing change.

Schieir O, Thombs BD, Hudson M, Taillefer S, Steele R, Berkson L, Bertrand C, Couture F, Fitzcharles MA, Gagné M, Garfield B, Gutkowski A, Kang H, Kapusta M, Ligier S, Mathieu JP, Ménard H, Mercille S, Starr M, Stein M, Zummer M, Baron M.

J Rheumatol. 2009 Feb;36(2):231-9. doi: 10.3899/jrheum.080147.

PMID:
19132790
28.

Steroid-sparing effects of methotrexate in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial.

Fortin PR, Abrahamowicz M, Ferland D, Lacaille D, Smith CD, Zummer M; Canadian Network For Improved Outcomes in Systemic Lupus.

Arthritis Rheum. 2008 Dec 15;59(12):1796-804. doi: 10.1002/art.24068.

29.

Implementing arthritis clinical practice guidelines in primary care.

Lineker SC, Bell MJ, Boyle J, Badley EM, Flakstad L, Fleming J, Lyddiatt A, Macdonald J, McCarthy J, Zummer M.

Med Teach. 2009 Mar;31(3):230-7. doi: 10.1080/01421590802158377.

PMID:
18825571
30.

Smoldering rheumatoid arthritis: is the Canadian healthcare system neglecting a significant disease population?

Edworthy S, Zummer M, Garner S, Boire G, Leclercq S, Bykerk V, Kraag G, Markland J, Thomas D, Thomson J, Henderson J.

J Rheumatol. 2008 Aug;35(8):1506-12. Epub 2008 Jun 15.

PMID:
18597407
31.

The clinimetric properties of the World Health Organization Disability Assessment Schedule II in early inflammatory arthritis.

Baron M, Schieir O, Hudson M, Steele R, Kolahi S, Berkson L, Couture F, Fitzcharles MA, Gagné M, Garfield B, Gutkowski A, Kang H, Kapusta M, Ligier S, Mathieu JP, Ménard H, Starr M, Stein M, Zummer M.

Arthritis Rheum. 2008 Mar 15;59(3):382-90. doi: 10.1002/art.23314.

32.

Delay in consultation with specialists for persons with suspected new-onset rheumatoid arthritis: a population-based study.

Feldman DE, Bernatsky S, Haggerty J, Leffondré K, Tousignant P, Roy Y, Xiao Y, Zummer M, Abrahamowicz M.

Arthritis Rheum. 2007 Dec 15;57(8):1419-25.

33.

The Canadian Rheumatology Association/ Spondyloarthritis Research Consortium of Canada treatment recommendations for the management of spondyloarthritis: a national multidisciplinary stakeholder project.

Maksymowych WP, Gladman D, Rahman P, Boonen A, Bykerk V, Choquette D, Dimond S, Fortin P, Karsh J, Klinkhoff AV, Mosher D, Mulholland K, Olszynski WP, Russell AS, Savage L, Shanner L, Shojania K, Starr M, Thomson G, Zummer M, Inman R; Canadian Rheumatology Association/ Spondyloarthritis Research Consortium of Canada.

J Rheumatol. 2007 Nov;34(11):2273-84. Epub 2007 Sep 15.

PMID:
17896800
34.

The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study.

Bernatsky S, Joseph L, Boivin JF, Gordon C, Urowitz M, Gladman D, Fortin PR, Ginzler E, Bae SC, Barr S, Edworthy S, Isenberg D, Rahman A, Petri M, Alarcón GS, Aranow C, Dooley MA, Rajan R, Sénécal JL, Zummer M, Manzi S, Ramsey-Goldman R, Clarke AE.

Ann Rheum Dis. 2008 Jan;67(1):74-9. Epub 2007 Jun 1.

PMID:
17545189
35.

Care pathways in early rheumatoid arthritis.

Bernatsky S, Feldman D, Shrier I, Toupin K, Haggerty J, Tousignant P, Zummer M.

Can Fam Physician. 2006 Nov;52(11):1444-5.

36.

Mortality related to cerebrovascular disease in systemic lupus erythematosus.

Bernatsky S, Clarke A, Gladman DD, Urowitz M, Fortin PR, Barr SG, Senécal JL, Zummer M, Edworthy S, Sibley J, Pope J, Ensworth S, Ramsey-Goldman R, Hanly JG.

Lupus. 2006;15(12):835-9.

PMID:
17211987
37.

Mortality in systemic lupus erythematosus.

Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, Dooley MA, Nived O, Sturfelt G, Steinsson K, Alarcón G, Senécal JL, Zummer M, Hanly J, Ensworth S, Pope J, Edworthy S, Rahman A, Sibley J, El-Gabalawy H, McCarthy T, St Pierre Y, Clarke A, Ramsey-Goldman R.

Arthritis Rheum. 2006 Aug;54(8):2550-7.

38.

An international cohort study of cancer in systemic lupus erythematosus.

Bernatsky S, Boivin JF, Joseph L, Rajan R, Zoma A, Manzi S, Ginzler E, Urowitz M, Gladman D, Fortin PR, Petri M, Edworthy S, Barr S, Gordon C, Bae SC, Sibley J, Isenberg D, Rahman A, Aranow C, Dooley MA, Steinsson K, Nived O, Sturfelt G, Alarcón G, Senécal JL, Zummer M, Hanly J, Ensworth S, Pope J, El-Gabalawy H, McCarthy T, St Pierre Y, Ramsey-Goldman R, Clarke A.

Arthritis Rheum. 2005 May;52(5):1481-90.

39.

Group psychotherapy reduces illness intrusiveness in systemic lupus erythematosus.

Edworthy SM, Dobkin PL, Clarke AE, Da Costa D, Dritsa M, Fortin PR, Barr S, Ensworth S, Esdaile JM, Beaulieu A, Zummer M, Senécal JL, Goulet JR, Choquette D, Rich E, Smith D, Cividino A, Gladman D, Devins GM.

J Rheumatol. 2003 May;30(5):1011-6.

PMID:
12734897
40.

Counterbalancing patient demands with evidence: results from a pan-Canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosus.

Dobkin PL, Da Costa D, Joseph L, Fortin PR, Edworthy S, Barr S, Ensworth S, Esdaile JM, Beaulieu A, Zummer M, Senécal JL, Goulet JR, Choquette D, Rich E, Smith D, Cividino A, Gladman D, St-Pierre Y, Clarke AE.

Ann Behav Med. 2002 Spring;24(2):88-99.

PMID:
12054324
41.

Living with lupus: a prospective pan-Canadian study.

Dobkin PL, Da Costa D, Fortin PR, Edworthy S, Barr S, Esdaile JM, Senécal JL, Goulet JR, Choquette D, Rich E, Beaulieu A, Cividino A, Ensworth S, Smith D, Zummer M, Gladman D, Clarke AE.

J Rheumatol. 2001 Nov;28(11):2442-8.

PMID:
11708416
42.

Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health.

Dobkin PL, Da Costa D, Dritsa M, Fortin PR, Senécal JL, Goulet JR, Choquette D, Rich E, Beaulieu A, Cividino A, Edworthy S, Barr S, Ensworth S, Esdaile JM, Gladman D, Smith D, Zummer M, Clarke AE.

Arthritis Care Res. 1999 Dec;12(6):401-10.

PMID:
11081011
43.

Determinants of health status in fibromyalgia: a comparative study with systemic lupus erythematosus.

Da Costa D, Dobkin PL, Fitzcharles MA, Fortin PR, Beaulieu A, Zummer M, Senécal JL, Goulet JR, Rich E, Choquette D, Clarke AE.

J Rheumatol. 2000 Feb;27(2):365-72.

PMID:
10685798
45.

Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial.

Shiroky JB, Neville C, Esdaile JM, Choquette D, Zummer M, Hazeltine M, Bykerk V, Kanji M, St-Pierre A, Robidoux L, et al.

Arthritis Rheum. 1993 Jun;36(6):795-803.

PMID:
8507221

Supplemental Content

Loading ...
Support Center